VAERS reports by lot

Pfizer COVID-19 lot EWO181: VAERS reports

29 VAERS reports list lot EWO181 as a Pfizer COVID-19 vaccine, received between 2021-06-20 and 2023-02-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
17%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2319%
Gastrointestinal1815%
Neurological1714%
Cardiac / Cardiovascular1614%
Respiratory1614%
Dermatological (non-injection-site)87%
Musculoskeletal65%
Thrombotic / Hematological43%
Reproductive / Menstrual43%
Autoimmune / Immune-mediated22%
Allergic / Anaphylactic22%
Psychiatric / Neuropsychiatric22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Ohio4
California2
Wisconsin2
New Hampshire2
Texas2
New Jersey2
Maryland1
Indiana1
Colorado1
North Carolina1
Massachusetts1

Reports by month received

2021-065
2021-0710
2021-084
2021-093
2021-101
2021-112
2022-011
2022-071
2022-111
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.